These clinical effects are certainly impressive in themselves, but the hype around these drugs can only be fully understood by considering the demographic trends which they may help address
London: Academic Press (2026)
Fotouhi A, Hagos WW, Ilic M, Wojcik A, Harms-Ringdahl M, de Gruijl F, et al
New Drug Formulations: The introduction of new medications or a lower-cost generic version in the future would significantly alter the outcome of this debate
While the gastrointestinal effects (nausea, diarrhea, vomiting) are similar to other GLP-1 medications like Wegovy and Mounjaro, retatrutide has one unique finding: dysesthesia (abnormal touch sensations) in 20.9% of patients at the 12mg dose in TRIUMPH-4, and 12.5% at 12mg in the larger TRIUMPH-1 trial
Do not change your dose without medical advice